Ambulatory leaders face a stark reality: cost pressures, staffing shortages and access bottlenecks are rising faster than resources can keep up. Yet expectations for growth and patient experience haven’t softened. According to a Becker’s survey, organizations are turning to seven…
Presented by:
Ellinwood (Kan.) Hospital and Clinic has named interim leaders as it continues its search for a new CEO. Amid the transition, CFO Summer Zink and Chief Nursing Officer Jill Ritchie, RN, were appointed co-interim CEOs, the hospital said in a…
Here are 33 health systems that have had their credit ratings upgraded by Fitch Ratings or Moody’s Investors Service in 2025: Advocate Health’s member organizations Advocate Aurora Health and Atrium Health were upgraded to “Aa2” from “Aa3,” and Atrium Health…
In this episode, Jakob Emerson, Associate News Director, Becker’s Healthcare, discusses consolidation across the Blue Cross Blue Shield system, rising friction between payers and providers over coding and denials, and how AI and upcoming CMS prior authorization rules are reshaping…
In this episode, Dr. Jackie Kissel and Dr. Alvin Choy share how Equitas Health built a streamlined, team based workflow to manage long acting injectable PrEP and HIV treatments, highlighting the critical role of communication, customized tracking tools, and clinical…
This episode, recorded live at the Becker’s 13th Annual CEO + CFO Roundtable features James Dover, President and CEO, Avera Health. He discusses Avera’s strategic plan, Luminate, the organization’s approach to AI and technology adoption, and how mission-driven leadership guides…
In this episode, John Mallia, Interim CFO, Methodist Le Bonheur Healthcare, discusses the key financial challenges facing health systems today, including workforce costs, payer pressures, and reimbursement uncertainty, while sharing how his organization is investing in Epic, revenue cycle partnerships,…
In this episode, Solomon Moshkevich, president of clinical diagnostics at Natera, discusses how molecular data, MRD testing, and AI-driven tools are transforming clinical decision making across oncology, prenatal care, and chronic kidney disease. He shares insights on evidence generation, system…
Researchers at the University of Missouri School of Medicine in Columbia tested an FDA-approved medical device designed to speed up autism diagnoses in areas with limited access to specialty care. The tool uses AI to analyze patient data and produce…
OpenEvidence, which has been called “ChatGPT for doctors,” is raising $250 million in equity financing at a $12 billion valuation, The Information reported. The three-year-old company, which secured $200 million in October to be valued at $6 billion, generates annual…
